SinaCurcumin®
A plant compound formulation.
General information
SinaCurcumin® is a nano-micellar formulation containing curcumin, bisdemethoxycurcumin, and desmethoxycurcumin (Tahmasebi et al., 2021).
Synonyms
Nanocurcumin
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial
Small molecule Non-randomized controlled open trial Moderate severity Mild severity Mixed substance |
Patients | 4.09 | Faster clinical improvement was observed in the treatment group. Sample size: 20 + 20 control. Dosage: 80 mg twice a day - "Sinacurcumin® soft gel" formulation containing "curcuminoids as nanomicelle". |
Jan/03/2021 |
|
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
Severe severity Randomized controlled double-blind trial Mild severity Mixed substance |
Patients | 3.65 | Observed to increase the count of regulatory T cells and levels of some of the cytokines secreted by these cells. Sample size: 34 severe (of which 15 received placebo) + 39 mild (of which 19 received placebo) + 40 healthy controls. Dosage: 80 mg twice a day for 21 days. |
Mar/28/2021 |
